Total Holdings
27
Portfolio diversification across 27 positions
OZEM
(NASDAQ)Roundhill GLP-1 & Weight Loss ETF
$31.90-- (--)
Loading... - Market loading
OZEM ETF Holdings: Roundhill GLP-1 & Weight Loss ETF
Complete portfolio holdings with allocation weights, sector breakdown, and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Assets Under Management
$56.91M
Total fund assets
Expense Ratio
0.59%
Annual management fee
Fund Issuer
Roundhill
NASDAQ
Portfolio Allocations
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
Top 33 Holdings by Portfolio Weight
View ticker symbols, company names, asset types, and allocation percentages for each position
Scroll to see more
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 |  | Novo Nordisk A/S | Stock | 18.28% |
| 2 |  | Eli Lilly and Company | Stock | 15.91% |
| 3 |  | Pfizer Inc. | Stock | 7.41% |
| 4 |  | Viking Therapeutics, Inc. | Stock | 5.49% |
| 5 | H HKG:1801 | Innovent Biologics, Inc. | Stock | 5.35% |
| 6 | H HKG:1672 | Ascletis Pharma Inc | Stock | 4.88% |
| 7 | S SWX:ROG | Roche Holding AG | Stock | 4.46% |
| 8 |  | Structure Therapeutics Inc. American Depositary Shares | Stock | 4.42% |
| 9 | T TSE:4519 | Chugai Pharmaceutical Co. Ltd. | Stock | 4.23% |
| 10 | C CO:ZEAL | Zealand Pharma A/S | Stock | 3.98% |
| 11 | S SWX:ROP | Roche Holding AG | Stock | 3.87% |
| 12 |  | Amgen Inc | Stock | 3.83% |
| 13 | L LON:AZN | AstraZeneca PLC | Stock | 3.77% |
| 14 | 4 4519.JP | Chugai Pharmaceutical Co Ltd | Stock | 3.58% |
| 15 | Z ZEAL.DC | Zealand Pharma A/S | Stock | 3.54% |
| 16 | K KRX:128940 | Hanmi Pharm. Co., Ltd. | Stock | 3.51% |
| 17 | H HKG:2196 | Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | Stock | 3.32% |
| 18 | L LSE:AZN | AstraZeneca PLC | Stock | 3.23% |
| 19 |  | Regeneron Pharmaceuticals, Inc. | Stock | 3.19% |
| 20 | H HKG:1093 | CSPC Pharmaceutical Group Limited | Stock | 3.04% |
| 21 | G GUBRA.DC | Gubra A/S | Stock | 2.42% |
| 22 | H HKG:3933 | The United Laboratories International Holdings Limited | Stock | 2.42% |
| 23 |  | Gilead Sciences, Inc | Stock | 2.18% |
| 24 |  | MBX Biosciences, Inc. | Stock | 2.14% |
| 25 | C CO:GUBRA | Gubra A/S | Stock | 2.01% |
| 26 |  | Scholar Rock Holding Corp | Stock | 2.01% |
| 27 | T TSE:4507 | Shionogi & Co. Ltd. | Stock | 1.67% |
| 28 |  | Rhythm Pharmaceuticals, Inc. | Stock | 1.38% |
| 29 | 4 4507.JP | Shionogi & Co Ltd | Stock | 1.37% |
| 30 |  | Biohaven Ltd. | Stock | 0.98% |
| 31 |  | Wave Life Sciences Ltd | Stock | 0.75% |
| 32 |  | Corbus Pharmaceuticals Holdings, Inc. | Stock | 0.43% |
| 33 | N NMFQS:FGXXX | - | Cash | 0.12% |
Frequently Asked Questions About Roundhill GLP-1 & Weight Loss ETF Holdings
What are the top holdings in OZEM?
Roundhill GLP-1 & Weight Loss ETF (OZEM) holds 27 securities. View the complete list of top holdings sorted by portfolio weight, showing each security's ticker symbol, company name, asset type, and allocation percentage.
How concentrated is OZEM's portfolio?
Portfolio concentration is measured by the weight of top holdings. A concentrated portfolio has fewer large positions with higher individual weights, while a diversified portfolio distributes holdings more evenly. Review OZEM's holdings table to analyze concentration risk.
What is OZEM's sector allocation?
The Sector Allocation chart shows how OZEM distributes investments across different industries like Technology, Healthcare, Financials, and more. This sector exposure helps understand the fund's industry diversification strategy.
What countries does OZEM invest in?
OZEM's geographic exposure is shown in the Countries tab under Portfolio Allocations. This reveals the fund's international diversification and exposure to different regions and global markets.
How diversified is OZEM ETF?
OZEM's diversification can be assessed by reviewing its 27 holdings, sector allocation, and geographic exposure. A well-diversified ETF spreads investments across multiple securities, sectors, and regions to reduce concentration risk.